Skip to main content

Table 2 Patients at risk according to Dutch CV-RM guideline risk scores and treatment

From: Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation

Dutch CV-RM guidelines Total N = 254 Indication for CV risk medication N = 51 Inadequately or not treated N = 39 Statins N = 7 Antihypertensive drugs N = 27 Both statin and antihypertensive N = 9
High risk >20% 9 9 9 2 2 1
Intermediate risk 10-20% 16 10 8 1 6 1
Low risk <10% 105 24 14 1 16 5
Secondary CV prevention 8 8 8 3 3 2
CV risk not determined* 116 N.A. N.A. 0 0 0
  1. NA; not applicable N; number of patients, CV; cardiovascular * Patients who could not be included because of age <40 years or missing cholesterol/blood pressure values.